Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists Didac Mauricio; Javier Escalada; Antonio Pérez; Manuel Romero-Gómez; Kenneth Cusi; Zobair M. Younoussi; Jeffrey V. Lazarus;

Is the Spanish type 1 diabetes mellitus registry really necessary? Javier Escalada; Antonio Pérez; Itxaso Rica;

Glycaemic control during the COVID-19 pandemic: A catastrophe or a sign of hope for the person with type 1 Diabetes Mellitus? Diogo Ramalho; Ana Rouxinol-Dias; Patrícia Tavares; Sara Correia; Lúcia Almeida; Helena Alves; Gustavo Rocha; Maria João Oliveira;